{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:12:34Z","timestamp":1774278754902,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371100"],"award-info":[{"award-number":["82371100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR1043B"],"award-info":[{"award-number":["SHDC2020CR1043B"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.exer.2025.110565","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:33Z","timestamp":1753890513000},"page":"110565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2"],"prefix":"10.1016","volume":"259","author":[{"given":"Linfeng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoge","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7006","key":"10.1016\/j.exer.2025.110565_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib2","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157: pathophysiology of graves' ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.exer.2025.110565_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current insights into the pathogenesis of graves' ophthalmopathy","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding graves' orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-017-0608-z","article-title":"Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active graves' orbitopathy?","volume":"40","author":"Bartalena","year":"2017","journal-title":"J. Endocrinol. Investig."},{"issue":"10","key":"10.1016\/j.exer.2025.110565_bib6","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s40618-023-02033-3","article-title":"Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for graves' orbitopathy","volume":"46","author":"Cao","year":"2023","journal-title":"J. Endocrinol. Investig."},{"issue":"6","key":"10.1016\/j.exer.2025.110565_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063288","article-title":"The role of fibrogenesis and extracellular matrix proteins in the pathogenesis of graves' ophthalmopathy","volume":"25","author":"Chiu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.exer.2025.110565_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270416","article-title":"MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase","volume":"17","author":"Choi","year":"2022","journal-title":"PLoS One"},{"issue":"52","key":"10.1016\/j.exer.2025.110565_bib9","doi-asserted-by":"crossref","first-page":"37319","DOI":"10.1074\/jbc.M113.492793","article-title":"Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-beta receptor signaling pathways contributes to renal fibrosis","volume":"288","author":"Chung","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exer.2025.110565_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010153","article-title":"miR-199a downregulation as a driver of the NOX4\/HIF-1alpha\/VEGF-A pathway in thyroid and orbital adipose tissues from graves' patients","volume":"23","author":"Craps","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.exer.2025.110565_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.63.10.6","article-title":"Potential therapeutic activity of berberine in thyroid-associated ophthalmopathy: inhibitory effects on tissue remodeling in orbital fibroblasts","volume":"63","author":"Diao","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.exer.2025.110565_bib12","first-page":"1566","article-title":"Histone deacetylase 4 controls extracellular matrix production in orbital fibroblasts from graves' ophthalmopathy patients","volume":"31","author":"Ekronarongchai","year":"2021","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.exer.2025.110565_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.62.1.29","article-title":"MicroRNA-130a is elevated in thyroid eye disease and increases lipid accumulation in fibroblasts through the suppression of AMPK","volume":"62","author":"Hammond","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110565_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/thy.2018.0285","article-title":"High-mobility group box 1 is associated with the inflammatory pathogenesis of graves' orbitopathy","volume":"29","author":"Han","year":"2019","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.exer.2025.110565_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/19382014.2015.1118195","article-title":"Thrombin stimulates insulin secretion via protease-activated receptor-3","volume":"7","author":"Hanzelmann","year":"2015","journal-title":"Islets"},{"issue":"1","key":"10.1016\/j.exer.2025.110565_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100206","article-title":"Identifying novel genes and variants in immune and coagulation pathways associated with macular degeneration","volume":"3","author":"Huan","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"10","key":"10.1016\/j.exer.2025.110565_bib17","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1167\/iovs.16-19213","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of graves' orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2025.110565_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bjophthalmol-2017-310723","article-title":"Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with graves' orbitopathy","volume":"102","author":"Jang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2025.110565_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221077","article-title":"MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with graves' orbitopathy","volume":"14","author":"Jang","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.exer.2025.110565_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib21","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1167\/iovs.16-20684","article-title":"Sphingosine-1-Phosphate mediates fibrosis in orbital fibroblasts in graves' orbitopathy","volume":"58","author":"Ko","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.exer.2025.110565_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-024-01016-5","article-title":"Graves disease: latest understanding of pathogenesis and treatment options","volume":"20","author":"Lanzolla","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.exer.2025.110565_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"11","key":"10.1016\/j.exer.2025.110565_bib24","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1096\/fj.202001377R","article-title":"The p38 signaling pathway mediates the TGF-beta1-induced increase in type I collagen deposition in human granulosa cells","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3892\/etm.2020.9165","article-title":"MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in graves' ophthalmopathy orbital fibroblasts","volume":"20","author":"Liu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.exer.2025.110565_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.12.18","article-title":"The potential role of osteopontin in the pathogenesis of graves' ophthalmopathy","volume":"62","author":"Lou","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"17","key":"10.1016\/j.exer.2025.110565_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179352","article-title":"Protease activated receptors and arthritis","volume":"22","author":"Lucena","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.exer.2025.110565_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101741","article-title":"MicroRNAs in autoimmune thyroid diseases and their role as biomarkers","volume":"37","author":"Martinez-Hernandez","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.exer.2025.110565_bib29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jc.2017-02318","article-title":"A MicroRNA signature for evaluation of risk and severity of autoimmune thyroid diseases","volume":"103","author":"Martinez-Hernandez","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.exer.2025.110565_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpain.2020.12.006","article-title":"A role for protease activated receptor type 3 (PAR3) in nociception demonstrated through development of a novel peptide agonist","volume":"22","author":"Mwirigi","year":"2021","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.exer.2025.110565_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","article-title":"2021 update on thyroid-associated ophthalmopathy","volume":"45","author":"Neag","year":"2022","journal-title":"J. Endocrinol. Investig."},{"issue":"6","key":"10.1016\/j.exer.2025.110565_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/scd.2019.0212","article-title":"Isolation and characterization of extraocular muscle-derived muscle progenitor cells from normal and graves' orbitopathy patients","volume":"29","author":"Park","year":"2020","journal-title":"Stem Cell. Dev."},{"issue":"6","key":"10.1016\/j.exer.2025.110565_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of graves' disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.exer.2025.110565_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/thy.2018.0544","article-title":"Basic fibroblast growth factor induces adipogenesis in orbital fibroblasts: implications for the pathogenesis of graves' orbitopathy","volume":"29","author":"Schrijver","year":"2019","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.exer.2025.110565_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12020-014-0487-4","article-title":"Circulating microRNA predicts insensitivity to glucocorticoid therapy in graves' ophthalmopathy","volume":"49","author":"Shen","year":"2015","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1074248413485434","article-title":"Protease-activated receptor 1 inhibition by SCH7 9797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts","volume":"18","author":"Sonin","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.exer.2025.110565_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098356","article-title":"Serelaxin alleviates fibrosis in thyroid-associated ophthalmopathy via the notch pathway","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110565_bib38","first-page":"324","article-title":"MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"21","author":"Tong","year":"2015","journal-title":"Mol. Vis."},{"issue":"11","key":"10.1016\/j.exer.2025.110565_bib39","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/en.2015-1399","article-title":"Pentraxin-3 is a TSH-inducible protein in human fibrocytes and orbital fibroblasts","volume":"156","author":"Wang","year":"2015","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.exer.2025.110565_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095261","article-title":"Disulfiram exerts antifibrotic and anti-inflammatory therapeutic effects on perimysial orbital fibroblasts in graves' orbitopathy","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110565_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fcell.2020.00818","article-title":"MicroRNAs and autoimmune-mediated eye diseases","volume":"8","author":"Wei","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.exer.2025.110565_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032712-095937","article-title":"The immunology of fibrosis","volume":"31","author":"Wick","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2025.110565_bib43","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1096\/fj.14-257121","article-title":"Thy1 (CD90) controls adipogenesis by regulating activity of the src family kinase","volume":"29","author":"Woeller","year":"2015","journal-title":"Fyn. FASEB J."},{"issue":"7","key":"10.1016\/j.exer.2025.110565_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2217\/rme-2022-0150","article-title":"miR-125b-5p alleviates the damage of myocardial infarction by inhibiting the NFAT2 to reduce F2RL2 expression","volume":"18","author":"Wu","year":"2023","journal-title":"Regen. Med."},{"issue":"1","key":"10.1016\/j.exer.2025.110565_bib45","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1038\/s41598-024-55575-8","article-title":"Identification of key genes for atherosclerosis in different arterial beds","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.exer.2025.110565_bib46","first-page":"295","article-title":"Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis","volume":"110","author":"Wygrecka","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.exer.2025.110565_bib47","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/iwj.14031","article-title":"Bioinformatics analysis and identification of dysregulated POSTN in the pathogenesis of keloid","volume":"20","author":"Xu","year":"2023","journal-title":"Int. Wound J."},{"issue":"4","key":"10.1016\/j.exer.2025.110565_bib48","first-page":"1801","article-title":"MicroRNA-146a contributes to CD4(+) T lymphocyte differentiation in patients with thyroid ophthalmopathy","volume":"9","author":"Yang","year":"2017","journal-title":"Am J Transl Res"},{"issue":"12","key":"10.1016\/j.exer.2025.110565_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.63.12.27","article-title":"Differential circular RNA expression profiling of orbital connective tissue from patients with type I and type II thyroid-associated ophthalmopathy","volume":"63","author":"Ye","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.exer.2025.110565_bib50","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1167\/iovs.12-9646","article-title":"Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of graves' orbitopathy","volume":"53","author":"Yoon","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525003367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525003367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:26:07Z","timestamp":1772799967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525003367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"alternative-id":["S0014483525003367"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110565","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110565"}}